Clinical trial
Prospective Cohort for the sEcoNDary Prevention of Ventricular Tachycardia in Patients With Cardiomyopathies (END-VT) Study
NCT05835791 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort for the sEcoNDary Prevention of Ventricular Tachycardia in Patients With Cardiomyopathies (END-VT) Study
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 12, 2024
- Completion date
- April 30, 2029
- Enrollment
- 2,454 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
icd, implantable defibrillator user, ventricular tachycardia